OR WAIT null SECS
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
Effective analytics will eliminate failures, deviations, and non-conformances.
March 02, 2011
INTERPHEX 2011 aims to address the industry's unique characteristics.
March 01, 2011
Use of in-process particle size analysis has enabled pharmaceutical scientists and process engineers to track the progress of a granulation process and detect its endpoint.
In wet granulation, many companies used to rely on empirical data and quality control, but processes and technologies have improved in a variety of ways in recent years.
February 24, 2011
Gilead to Acquire Calistoga; Bayer Healthcare Appoints Former Pfizer Exec; and More.
February 17, 2011
Company and People Notes: sanofi to Acquire Genzyme; Lilly Makes Senior Appointments; and More.
February 16, 2011
My drug failed a light-obscuration test, but after I filtered the drug for microscopic particle counting, I couldn?t see any significant particulate on the filter. What might have caused the failure, and why is it not visible?
February 11, 2011
The way in which a suspension nasal spray product interacts with the body depends not only on the droplet size of the delivered droplet, but also on the particle size of the suspended API.
February 10, 2011
Pfizer Acquires Ferrosan's Consumer Health Business; Patheon Appoints Former Biogen Exec as CEO; and More.
February 03, 2011
Company and People Notes: Pfizer Completes King Tender Offer; Cook Pharmica Names VP of R&D and CSO; and More
February 02, 2011
Follow-ons were all the rage at this year's JP Morgan Healthcare Conference.